Drug Abuse Testing Market by Product & Services (Analyzers, Rapid Testing Devices, Consumables, and Laboratory Services), Sample Type (Urine, Oral Fluid, Breath, Hair, and Others), and End User (Workplaces & Schools, Criminal Justice Systems & Law Enforcement Agencies, Research Laboratories, and Hospitals): Global Opportunity Analysis and Industry Forecast, 2018 - 2025
Drug Abuse Testing Market Overview:
The global drug abuse testing market was valued at $6,244 million in 2017 and is expected to reach $11,833 million by 2025, registering a CAGR of 8.2% from 2018 to 2025.
A drug test is primarily performed to confirm the presence of one or more illegal or prescription drugs in a person’s urine, blood, saliva, hair, or sweat. The test is performed by using the samples such as urine, hair, blood, saliva, and others. Among these urine sample is the most widely preferred owing to the advantages it offers, such as lower test cost, availability of more sample, and availability of point-of-care tests. Drug testing offers a critical adjunct to clinical care and substance use. The most often tested drugs include marijuana, opioids, cocaine, morphine, and others. Drug tests are increasingly being adopted by sports organizations, employers, forensic purposes, and several other applications.
The surge in consumption of alcohol and illicit drugs across the globe is one of the major drivers for the drug testing market. In addition, technological advancements toward the development of more accurate and precise testing devices and stringent government regulations mandating drug abuse monitoring further boost the market growth. However, lack of awareness and consideration of drug testing as a breach of privacy rights in certain countries restrict the growth of the global market. On the contrary, emerging markets such as the Asia-Pacific and LAMEA, provide lucrative growth opportunities for the market.
The global drug abuse testing market is segmented based on products & services, sample type, end user, and region. Based on products & services, it is divided into equipment, rapid testing devices (RTD), consumables, and laboratory services. Based on equipment, it is further categorized into immunoassay analyzers, chromatography instruments, and breath analyzers. Based on RTD, it is bifurcated into urine testing devices and oral fluid/saliva testing devices. Based on consumables, it is divided into assay kits, sample collection cups, calibrators & controls, and other consumables. Based on sample type, the market is divided into urine sample, breath sample, oral fluid sample, hair sample, and others.
Based on end user, it is segmented into workplace & school, drug testing laboratories, criminal justice & law enforcement agencies, hospitals, pain management centers, and personal users. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Benefits for drug abuse testing market:
By Product & Services
The global drug abuse testing market was valued at $6,244 million in 2017 and is expected to reach $11,833 million by 2025, registering a CAGR of 8.2% from 2018 to 2025.
A drug test is primarily performed to confirm the presence of one or more illegal or prescription drugs in a person’s urine, blood, saliva, hair, or sweat. The test is performed by using the samples such as urine, hair, blood, saliva, and others. Among these urine sample is the most widely preferred owing to the advantages it offers, such as lower test cost, availability of more sample, and availability of point-of-care tests. Drug testing offers a critical adjunct to clinical care and substance use. The most often tested drugs include marijuana, opioids, cocaine, morphine, and others. Drug tests are increasingly being adopted by sports organizations, employers, forensic purposes, and several other applications.
The surge in consumption of alcohol and illicit drugs across the globe is one of the major drivers for the drug testing market. In addition, technological advancements toward the development of more accurate and precise testing devices and stringent government regulations mandating drug abuse monitoring further boost the market growth. However, lack of awareness and consideration of drug testing as a breach of privacy rights in certain countries restrict the growth of the global market. On the contrary, emerging markets such as the Asia-Pacific and LAMEA, provide lucrative growth opportunities for the market.
The global drug abuse testing market is segmented based on products & services, sample type, end user, and region. Based on products & services, it is divided into equipment, rapid testing devices (RTD), consumables, and laboratory services. Based on equipment, it is further categorized into immunoassay analyzers, chromatography instruments, and breath analyzers. Based on RTD, it is bifurcated into urine testing devices and oral fluid/saliva testing devices. Based on consumables, it is divided into assay kits, sample collection cups, calibrators & controls, and other consumables. Based on sample type, the market is divided into urine sample, breath sample, oral fluid sample, hair sample, and others.
Based on end user, it is segmented into workplace & school, drug testing laboratories, criminal justice & law enforcement agencies, hospitals, pain management centers, and personal users. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Benefits for drug abuse testing market:
- The study provides an in-depth analysis of the global drug abuse testing market along with the current trends and future estimations to elucidate the imminent investment pockets.
- A comprehensive analysis of the factors that drive and restrict the market growth is provided.
- A comprehensive quantitative analysis of the industry is provided from 2018 to 2025 to assist stakeholders to capitalize on the prevailing market opportunities.
- An extensive analysis of the key segments of the industry helps understand the global trends in the sleep apnea diagnostics market.
- Key players and their strategies are provided to understand the competitive outlook of the industry.
By Product & Services
- Analyzers
- Consumables
- Rapid Testing Devices
- Laboratory Services
- Urine
- Oral Fluid (Saliva)
- Hair
- Breath
- Others
- Workplaces & Schools
- Criminal Justice Systems and Law Enforcement Agencies
- Research Laboratories
- Hospitals
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- France
- Germany
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
- LAMEA
- Saudi Arabia
- South Africa
- Brazil
- Turkey
- Rest of LAMEA
- Dr?gerwerk AG & Co
- Abbott Laboratories
- Hoffmann-La Roche AG
- Bio Rad Laboratories, Inc.
- Siemens AG
- Thermo Fisher Scientific, Inc.
- Danaher Corporation
- Quest Diagnostics Incorporated
- Express Diagnostics International Inc.
- Laboratory Corporation of America Holdings
- OraSure
- Alfa Scientific Designs
- Lifeloc
- MPD, Inc
- Premier Biotech
- Shimadzu
- Psychemedics
- SureHire
- CannAmm
- Omega Laboratories
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for the stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porters five forces analysis
3.4. Market share analysis, 2017
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Stringent government regulations regarding drug abuse
3.5.1.2. Rise in awareness against drug abuse
3.5.1.3. Development of novel drug testing equipment
3.5.2. Restraints
3.5.2.1. Consideration of drug abuse testing as a violation of rights
3.5.2.2. Possible manipulation of drug screening tests
3.5.3. Opportunities
3.5.3.1. Development of novel drug screening tests
CHAPTER 4: DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE
4.1. Overview
4.1.1. Market size and forecast
4.2. Analyzers
4.2.1. Key trends and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.2.4. Immunoassay analyzers
4.2.4.1. Market size and forecast
4.2.5. Chromatography analyzers
4.2.5.1. Market size and forecast
4.2.6. Breath analyzers
4.2.6.1. Market size and forecast
4.3. Rapid Testing Devices
4.3.1. Key trends and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.3.4. Urine testing devices
4.3.4.1. Market size and forecast
4.3.4.2. Urine testing devices, by type market size and forecast
4.3.4.2.1. Market size and forecast
4.3.5. Oral fluid testing devices
4.3.5.1. Market size and forecast
4.4. Consumables
4.4.1. Key trends and opportunities
4.4.1.1. Market size and forecast
4.4.2. Market analysis, by country
4.4.2.1. Assay kits
4.4.2.1.1. Market size and forecast
4.4.2.2. Sample collection cups
4.4.2.2.1. Market size and forecast
4.4.2.3. Calibrators and controls
4.4.2.3.1. Market size and forecast
4.4.2.4. Others
4.4.2.4.1. Market size and forecast
4.5. Laboratory Services
4.5.1. Key trends and opportunities
4.5.2. Market size and forecast
4.5.3. Market analysis, by country
CHAPTER 5: DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Urine
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.2.3. Oral Fluid
5.2.3.1. Market size and forecast
5.2.4. Market analysis, by country
5.2.5. Breath
5.2.5.1. Market size and forecast
5.2.6. Market analysis, by country
5.2.7. Hair
5.2.7.1. Market size and forecast
5.2.8. Market analysis, by country
5.2.9. Other Samples
5.2.9.1. Market size and forecast
5.2.10. Market analysis, by country
CHAPTER 6: DRUG ABUSE TESTING MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Workplaces and Schools
6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.3. Criminal Justice Systems and Law Enforcement Agencies
6.3.1. Market size and forecast
6.3.2. Market analysis, by country
6.4. Research laboratories
6.4.1. Market size and forecast
6.4.2. Market analysis, by country
6.5. Hospitals
6.5.1. Market size and forecast
6.5.2. Market analysis, by country
CHAPTER 7: DRUG ABUSE TESTING MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. North America market size and forecast, by country
7.2.2.1. U.S. market size and forecast, by product & service
7.2.2.2. U.S. market size and forecast, by sample type
7.2.2.3. U.S. market size and forecast, by end user
7.2.2.4. Canada market size and forecast, by product & service
7.2.2.5. Canada market size and forecast, by sample type
7.2.2.6. Canada market size and forecast, by end user
7.2.2.7. Mexico market size and forecast, by product & service
7.2.2.8. Mexico market size and forecast, by sample type
7.2.2.9. Mexico market size and forecast, by end user
7.2.2.10. North America market size and forecast, by product & service
7.2.3. North America market size and forecast, by sample type
7.2.4. North America market size and forecast, by end user
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Europe market size and forecast, by country
7.3.2.1. Germany market size and forecast, by product & service
7.3.2.2. Germany market size and forecast, by sample type
7.3.2.3. Germany market size and forecast, by end user
7.3.2.4. UK market size and forecast, by product & service
7.3.2.5. UK market size and forecast, by sample type
7.3.2.6. UK market size and forecast, by end user
7.3.2.7. France market size and forecast, by product & service
7.3.2.8. France market size and forecast, by sample type
7.3.2.9. France market size and forecast, by end user
7.3.2.10. Rest of Europe market size and forecast, by product & service
7.3.2.11. Rest of Europe market size and forecast, by sample type
7.3.2.12. Rest of Europe market size and forecast, by end user
7.3.3. Europe market size and forecast, by product & service
7.3.4. Europe market size and forecast, by sample type
7.3.5. Europe market size and forecast, by end user
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Asia-Pacific market size and forecast, by country
7.4.2.1. Japan market size and forecast, by product & service
7.4.2.2. Japan market size and forecast, by sample type
7.4.2.3. Japan market size and forecast, by end user
7.4.2.4. China market size and forecast, by product & service
7.4.2.5. China market size and forecast, by sample type
7.4.2.6. China market size and forecast, by end user
7.4.2.7. India market size and forecast, by product & service
7.4.2.8. India market size and forecast, by sample type
7.4.2.9. India market size and forecast, by end user
7.4.2.10. Australia market size and forecast, by product & service
7.4.2.11. Australia market size and forecast, by sample type
7.4.2.12. Australia market size and forecast, by end user
7.4.2.13. Rest of Asia-Pacific market size and forecast, by product & service
7.4.2.14. Rest of Asia-Pacific market size and forecast, by sample type
7.4.3. Rest of Asia-Pacific market size and forecast, by end user
7.4.4. Asia-Pacific market size and forecast, by product & service
7.4.5. Asia-Pacific market size and forecast, by sample type
7.4.6. Asia-Pacific market size and forecast, by end user
7.5. LAMEA
7.5.1. Key market trends and opportunities
7.5.2. LAMEA market size and forecast, by country
7.5.2.1. Brazil market size and forecast, by product & service
7.5.2.2. Brazil market size and forecast, by sample type
7.5.2.3. Brazil market size and forecast, by end user
7.5.2.4. South Africa market size and forecast, by product & service
7.5.2.5. South Africa market size and forecast, by sample type
7.5.2.6. South Africa market size and forecast, by end user
7.5.2.7. Saudi Arabia market size and forecast, by product & service
7.5.2.8. Saudi Arabia market size and forecast, by sample type
7.5.2.9. Saudi Arabia market size and forecast, by end user
7.5.2.10. Turkey market size and forecast, by product & service
7.5.2.11. Turkey market size and forecast, by sample type
7.5.2.12. Turkey market size and forecast, by end user
7.5.2.13. Rest of LAMEA market size and forecast, by product & service
7.5.2.14. Rest of LAMEA market size and forecast, by sample type
7.5.2.15. Rest of LAMEA market size and forecast, by end user
7.5.3. LAMEA market size and forecast, by product & service
7.5.4. LAMEA market size and forecast, by sample type
7.5.5. LAMEA market size and forecast, by end user
CHAPTER 8: COMPANY PROFILES
8.1. ABBOTT LABORATORIES
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. BIO-RAD LABORATORIES INC.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Business performance
8.2.5. Product portfolio
8.3. DANAHER CORPORATION
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.4. DRGERWERK AG & CO. KGAA
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.5. EXPRESS DIAGNOSTICS INTERNATIONAL INC.
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Product portfolio
8.5.4. Key strategic moves and developments
8.6. F. HOFFMANN-LA ROCHE LTD. (GENENTECH INC.)
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.7. LABORATORY CORPORATION OF AMERICA HOLDINGS
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.8. QUEST DIAGNOSTICS INCORPORATED
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.9. SIEMENS AG
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.10. THERMO FISHER SCIENTIFIC INC.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
1.1. Report description
1.2. Key benefits for the stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porters five forces analysis
3.4. Market share analysis, 2017
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Stringent government regulations regarding drug abuse
3.5.1.2. Rise in awareness against drug abuse
3.5.1.3. Development of novel drug testing equipment
3.5.2. Restraints
3.5.2.1. Consideration of drug abuse testing as a violation of rights
3.5.2.2. Possible manipulation of drug screening tests
3.5.3. Opportunities
3.5.3.1. Development of novel drug screening tests
CHAPTER 4: DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE
4.1. Overview
4.1.1. Market size and forecast
4.2. Analyzers
4.2.1. Key trends and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.2.4. Immunoassay analyzers
4.2.4.1. Market size and forecast
4.2.5. Chromatography analyzers
4.2.5.1. Market size and forecast
4.2.6. Breath analyzers
4.2.6.1. Market size and forecast
4.3. Rapid Testing Devices
4.3.1. Key trends and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.3.4. Urine testing devices
4.3.4.1. Market size and forecast
4.3.4.2. Urine testing devices, by type market size and forecast
4.3.4.2.1. Market size and forecast
4.3.5. Oral fluid testing devices
4.3.5.1. Market size and forecast
4.4. Consumables
4.4.1. Key trends and opportunities
4.4.1.1. Market size and forecast
4.4.2. Market analysis, by country
4.4.2.1. Assay kits
4.4.2.1.1. Market size and forecast
4.4.2.2. Sample collection cups
4.4.2.2.1. Market size and forecast
4.4.2.3. Calibrators and controls
4.4.2.3.1. Market size and forecast
4.4.2.4. Others
4.4.2.4.1. Market size and forecast
4.5. Laboratory Services
4.5.1. Key trends and opportunities
4.5.2. Market size and forecast
4.5.3. Market analysis, by country
CHAPTER 5: DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Urine
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.2.3. Oral Fluid
5.2.3.1. Market size and forecast
5.2.4. Market analysis, by country
5.2.5. Breath
5.2.5.1. Market size and forecast
5.2.6. Market analysis, by country
5.2.7. Hair
5.2.7.1. Market size and forecast
5.2.8. Market analysis, by country
5.2.9. Other Samples
5.2.9.1. Market size and forecast
5.2.10. Market analysis, by country
CHAPTER 6: DRUG ABUSE TESTING MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Workplaces and Schools
6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.3. Criminal Justice Systems and Law Enforcement Agencies
6.3.1. Market size and forecast
6.3.2. Market analysis, by country
6.4. Research laboratories
6.4.1. Market size and forecast
6.4.2. Market analysis, by country
6.5. Hospitals
6.5.1. Market size and forecast
6.5.2. Market analysis, by country
CHAPTER 7: DRUG ABUSE TESTING MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. North America market size and forecast, by country
7.2.2.1. U.S. market size and forecast, by product & service
7.2.2.2. U.S. market size and forecast, by sample type
7.2.2.3. U.S. market size and forecast, by end user
7.2.2.4. Canada market size and forecast, by product & service
7.2.2.5. Canada market size and forecast, by sample type
7.2.2.6. Canada market size and forecast, by end user
7.2.2.7. Mexico market size and forecast, by product & service
7.2.2.8. Mexico market size and forecast, by sample type
7.2.2.9. Mexico market size and forecast, by end user
7.2.2.10. North America market size and forecast, by product & service
7.2.3. North America market size and forecast, by sample type
7.2.4. North America market size and forecast, by end user
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Europe market size and forecast, by country
7.3.2.1. Germany market size and forecast, by product & service
7.3.2.2. Germany market size and forecast, by sample type
7.3.2.3. Germany market size and forecast, by end user
7.3.2.4. UK market size and forecast, by product & service
7.3.2.5. UK market size and forecast, by sample type
7.3.2.6. UK market size and forecast, by end user
7.3.2.7. France market size and forecast, by product & service
7.3.2.8. France market size and forecast, by sample type
7.3.2.9. France market size and forecast, by end user
7.3.2.10. Rest of Europe market size and forecast, by product & service
7.3.2.11. Rest of Europe market size and forecast, by sample type
7.3.2.12. Rest of Europe market size and forecast, by end user
7.3.3. Europe market size and forecast, by product & service
7.3.4. Europe market size and forecast, by sample type
7.3.5. Europe market size and forecast, by end user
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Asia-Pacific market size and forecast, by country
7.4.2.1. Japan market size and forecast, by product & service
7.4.2.2. Japan market size and forecast, by sample type
7.4.2.3. Japan market size and forecast, by end user
7.4.2.4. China market size and forecast, by product & service
7.4.2.5. China market size and forecast, by sample type
7.4.2.6. China market size and forecast, by end user
7.4.2.7. India market size and forecast, by product & service
7.4.2.8. India market size and forecast, by sample type
7.4.2.9. India market size and forecast, by end user
7.4.2.10. Australia market size and forecast, by product & service
7.4.2.11. Australia market size and forecast, by sample type
7.4.2.12. Australia market size and forecast, by end user
7.4.2.13. Rest of Asia-Pacific market size and forecast, by product & service
7.4.2.14. Rest of Asia-Pacific market size and forecast, by sample type
7.4.3. Rest of Asia-Pacific market size and forecast, by end user
7.4.4. Asia-Pacific market size and forecast, by product & service
7.4.5. Asia-Pacific market size and forecast, by sample type
7.4.6. Asia-Pacific market size and forecast, by end user
7.5. LAMEA
7.5.1. Key market trends and opportunities
7.5.2. LAMEA market size and forecast, by country
7.5.2.1. Brazil market size and forecast, by product & service
7.5.2.2. Brazil market size and forecast, by sample type
7.5.2.3. Brazil market size and forecast, by end user
7.5.2.4. South Africa market size and forecast, by product & service
7.5.2.5. South Africa market size and forecast, by sample type
7.5.2.6. South Africa market size and forecast, by end user
7.5.2.7. Saudi Arabia market size and forecast, by product & service
7.5.2.8. Saudi Arabia market size and forecast, by sample type
7.5.2.9. Saudi Arabia market size and forecast, by end user
7.5.2.10. Turkey market size and forecast, by product & service
7.5.2.11. Turkey market size and forecast, by sample type
7.5.2.12. Turkey market size and forecast, by end user
7.5.2.13. Rest of LAMEA market size and forecast, by product & service
7.5.2.14. Rest of LAMEA market size and forecast, by sample type
7.5.2.15. Rest of LAMEA market size and forecast, by end user
7.5.3. LAMEA market size and forecast, by product & service
7.5.4. LAMEA market size and forecast, by sample type
7.5.5. LAMEA market size and forecast, by end user
CHAPTER 8: COMPANY PROFILES
8.1. ABBOTT LABORATORIES
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. BIO-RAD LABORATORIES INC.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Business performance
8.2.5. Product portfolio
8.3. DANAHER CORPORATION
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.4. DRGERWERK AG & CO. KGAA
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.5. EXPRESS DIAGNOSTICS INTERNATIONAL INC.
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Product portfolio
8.5.4. Key strategic moves and developments
8.6. F. HOFFMANN-LA ROCHE LTD. (GENENTECH INC.)
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.7. LABORATORY CORPORATION OF AMERICA HOLDINGS
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.8. QUEST DIAGNOSTICS INCORPORATED
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.9. SIEMENS AG
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.10. THERMO FISHER SCIENTIFIC INC.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
LIST OF TABLES
TABLE 01. GLOBAL DRUG ABUSE TESTING MARKET, FOR PRODUCT & SERVICE BY REGION, 20172025 ($MILLION)
TABLE 02. GLOBAL DRUG ABUSE TESTING MARKET, FOR ANALYZERS BY REGION, 20172025 ($MILLION)
TABLE 03. GLOBAL DRUG ABUSE TESTING MARKET, FOR RAPID TESTING DEVICES BY REGION, 20172025 ($MILLION)
TABLE 04. GLOBAL URINE TESTING DEVICES MARKET, BY REGION, 20172025 ($MILLION)
TABLE 05. GLOBAL URINE TESTING DEVICES MARKET, BY TTYPE, 20172025 ($MILLION)
TABLE 06. GLOBAL SKIN DRUG ABUSE TESTING MARKET, BY REGION, 20172025 ($MILLION)
TABLE 07. CONSUMABLES MARKET, BY REGION, 20172025 ($MILLION)
TABLE 08. GLOBAL ASSAY KITS MARKET, BY REGION, 20172025 ($MILLION)
TABLE 09. GLOBAL SAMPLE CUPS MARKET, BY REGION, 20172025 ($MILLION)
TABLE 10. GLOBAL CALIBRATORS AND CONTROLS MARKET, BY REGION, 20172025 ($MILLION)
TABLE 11. GLOBAL OTHER CONSUMABLES MARKET, BY REGION, 20172025 ($MILLION)
TABLE 12. GLOBAL DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 13. GLOBAL DRUG ABUSE TESTING MARKET FOR URINE, BY REGION, 20172025 ($MILLION)
TABLE 14. GLOBAL DRUG ABUSE TESTING MARKET FOR ORAL FLUID, BY REGION, 20172025 ($MILLION)
TABLE 15. GLOBAL DRUG ABUSE TESTING MARKET FOR BREATH, BY REGION, 20172025 ($MILLION)
TABLE 16. GLOBAL DRUG ABUSE TESTING MARKET FOR HAIR, BY REGION, 20172025 ($MILLION)
TABLE 17. GLOBAL DRUG ABUSE TESTING MARKET FOR OTHER SAMPLES, BY REGION, 20172025 ($MILLION)
TABLE 18. GLOBAL DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 19. DRUG ABUSE TESTING MARKET FOR WORKPLACES AND SCHOOLS, BY REGION, 20172025 ($MILLION)
TABLE 20. DRUG ABUSE TESTING MARKET FOR CRIMINIAL JUSTICE SYSTEMS & LAW ENFORCEMENT AGENCIES, BY REGION, 20172025 ($MILLION)
TABLE 21. DRUG ABUSE TESTING MARKET FOR RESEARCH LABORATORIES, BY REGION, 20172025 ($MILLION
TABLE 22. GLOBAL DRUG ABUSE TESTING MARKET FOR HOSPITALS BY REGION, 20172025 ($MILLION)
TABLE 23. DRUG ABUSE TESTING MARKET, BY REGION, 20172025 ($MILLION)
TABLE 24. NORTH AMERICA DRUG ABUSE TESTING MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 25. U.S. DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE, 20172025 ($MILLION)
TABLE 26. U.S. DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 27. U.S. DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 28. CANADA DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE, 20172025 ($MILLION)
TABLE 29. CANADA DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 30. CANADA DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 31. MEXICO DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE, 20172025 ($MILLION)
TABLE 32. MEXICO DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 33. MEXICO DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 34. NORTH AMERICA DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE, 20172025 ($MILLION)
TABLE 35. NORTH AMERICA DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 36. NORTH AMERICA DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 37. EUROPE DRUG ABUSE TESTING MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 38. GERMANY DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE, 20172025 ($MILLION)
TABLE 39. GERMANY DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 40. GERMANY DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 41. UK DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE, 20172025 ($MILLION)
TABLE 42. UK DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 43. UK DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 44. FRANCE DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE, 20172025 ($MILLION)
TABLE 45. FRANCE DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 46. FRANCE DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 47. REST OF EUROPE DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE, 20172025 ($MILLION)
TABLE 48. REST OF EUROPE DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 49. REST OF EUROPE DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 50. EUROPE DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE, 20172025 ($MILLION)
TABLE 51. EUROPE DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 52. EUROPE DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 53. ASIA-PACIFIC DRUG ABUSE TESTING MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 54. JAPAN DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE, 20172025 ($MILLION)
TABLE 55. JAPAN DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 56. JAPAN DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 57. CHINA DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE, 20172025 ($MILLION)
TABLE 58. CHINA DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 59. CHINA DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 60. INDIA DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE, 20172025 ($MILLION)
TABLE 61. INDIA DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 62. INDIA DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 63. AUSTRALIA DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE, 20172025 ($MILLION)
TABLE 64. AUSTRALIA DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 65. AUSTRALIA DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 66. REST OF ASIA-PACIFIC DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE, 20172025 ($MILLION)
TABLE 67. REST OF ASIA-PACIFIC DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 68. REST OF ASIA-PACIFIC DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 69. ASIA-PACIFIC DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE, 20172025 ($MILLION)
TABLE 70. ASIA-PACIFIC DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 71. ASIA-PACIFIC DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 72. LAMEA DRUG ABUSE TESTING MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 73. BRAZIL DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE, 20172025 ($MILLION)
TABLE 74. BRAZIL DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 75. BRAZIL DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 76. SOUTH AFRICA DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE, 20172025 ($MILLION)
TABLE 77. SOUTH AFRICA DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 78. SOUTH AFRICA DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 79. SAUDI ARABIA DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE, 20172025 ($MILLION)
TABLE 80. SAUDI ARABIA DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 81. SAUDI ARABIA DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 82. TURKEY DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE, 20172025 ($MILLION)
TABLE 83. TURKEY DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 84. TURKEY DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 85. REST OF LAMEA DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE, 20172025 ($MILLION)
TABLE 86. REST OF LAMEA DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 87. REST OF LAMEA DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 88. LAMEA DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE, 20172025 ($MILLION)
TABLE 89. LAMEA DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 90. LAMEA DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 91. ABBOTT: COMPANY SNAPSHOT
TABLE 92. ABBOTT: OPERATING SEGMENTS
TABLE 93. ABBOTT: PRODUCT PORTFOLIO
TABLE 94. BIO-RAD: COMPANY SNAPSHOT
TABLE 95. BIO-RAD: OPERATING SEGMENTS
TABLE 96. BIORAD: PRODUCT PORTFOLIO
TABLE 97. DANAHER: COMPANY SNAPSHOT
TABLE 98. DANAHER: OPERATING SEGMENTS
TABLE 99. DANAHER: PRODUCT PORTFOLIO
TABLE 100. DRGER: COMPANY SNAPSHOT
TABLE 101. DRGER: PRODUCT PORTFOLIO
TABLE 102. EXPRESS DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 103. EXPRESS DIAGNOSTICS: PRODUCT PORTFOLIO
TABLE 104. ROCHE: COMPANY SNAPSHOT
TABLE 105. ROCHE: OPERATING SEGMENTS
TABLE 106. ROCHE: PRODUCT PORTFOLIO
TABLE 107. LABCORP: COMPANY SNAPSHOT
TABLE 108. LABCORP: OPERATING SEGMENTS
TABLE 109. LABCORP: PRODUCT PORTFOLIO
TABLE 110. QUEST: COMPANY SNAPSHOT
TABLE 111. QUEST: OPERATING SEGMENTS
TABLE 112. QUEST: PRODUCT PORTFOLIO
TABLE 113. SEIMENS: COMPANY SNAPSHOT
TABLE 114. SEIMENS: PRODUCT SEGMENTS
TABLE 115. SEIMENS: PRODUCT PORTFOLIO
TABLE 116. THERMO FISHER: COMPANY SNAPSHOT
TABLE 117. THERMO FISHER: OPERATING SEGMENTS
TABLE 118. THERMO FISHER: PRODUCT PORTFOLIO
TABLE 01. GLOBAL DRUG ABUSE TESTING MARKET, FOR PRODUCT & SERVICE BY REGION, 20172025 ($MILLION)
TABLE 02. GLOBAL DRUG ABUSE TESTING MARKET, FOR ANALYZERS BY REGION, 20172025 ($MILLION)
TABLE 03. GLOBAL DRUG ABUSE TESTING MARKET, FOR RAPID TESTING DEVICES BY REGION, 20172025 ($MILLION)
TABLE 04. GLOBAL URINE TESTING DEVICES MARKET, BY REGION, 20172025 ($MILLION)
TABLE 05. GLOBAL URINE TESTING DEVICES MARKET, BY TTYPE, 20172025 ($MILLION)
TABLE 06. GLOBAL SKIN DRUG ABUSE TESTING MARKET, BY REGION, 20172025 ($MILLION)
TABLE 07. CONSUMABLES MARKET, BY REGION, 20172025 ($MILLION)
TABLE 08. GLOBAL ASSAY KITS MARKET, BY REGION, 20172025 ($MILLION)
TABLE 09. GLOBAL SAMPLE CUPS MARKET, BY REGION, 20172025 ($MILLION)
TABLE 10. GLOBAL CALIBRATORS AND CONTROLS MARKET, BY REGION, 20172025 ($MILLION)
TABLE 11. GLOBAL OTHER CONSUMABLES MARKET, BY REGION, 20172025 ($MILLION)
TABLE 12. GLOBAL DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 13. GLOBAL DRUG ABUSE TESTING MARKET FOR URINE, BY REGION, 20172025 ($MILLION)
TABLE 14. GLOBAL DRUG ABUSE TESTING MARKET FOR ORAL FLUID, BY REGION, 20172025 ($MILLION)
TABLE 15. GLOBAL DRUG ABUSE TESTING MARKET FOR BREATH, BY REGION, 20172025 ($MILLION)
TABLE 16. GLOBAL DRUG ABUSE TESTING MARKET FOR HAIR, BY REGION, 20172025 ($MILLION)
TABLE 17. GLOBAL DRUG ABUSE TESTING MARKET FOR OTHER SAMPLES, BY REGION, 20172025 ($MILLION)
TABLE 18. GLOBAL DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 19. DRUG ABUSE TESTING MARKET FOR WORKPLACES AND SCHOOLS, BY REGION, 20172025 ($MILLION)
TABLE 20. DRUG ABUSE TESTING MARKET FOR CRIMINIAL JUSTICE SYSTEMS & LAW ENFORCEMENT AGENCIES, BY REGION, 20172025 ($MILLION)
TABLE 21. DRUG ABUSE TESTING MARKET FOR RESEARCH LABORATORIES, BY REGION, 20172025 ($MILLION
TABLE 22. GLOBAL DRUG ABUSE TESTING MARKET FOR HOSPITALS BY REGION, 20172025 ($MILLION)
TABLE 23. DRUG ABUSE TESTING MARKET, BY REGION, 20172025 ($MILLION)
TABLE 24. NORTH AMERICA DRUG ABUSE TESTING MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 25. U.S. DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE, 20172025 ($MILLION)
TABLE 26. U.S. DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 27. U.S. DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 28. CANADA DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE, 20172025 ($MILLION)
TABLE 29. CANADA DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 30. CANADA DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 31. MEXICO DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE, 20172025 ($MILLION)
TABLE 32. MEXICO DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 33. MEXICO DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 34. NORTH AMERICA DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE, 20172025 ($MILLION)
TABLE 35. NORTH AMERICA DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 36. NORTH AMERICA DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 37. EUROPE DRUG ABUSE TESTING MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 38. GERMANY DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE, 20172025 ($MILLION)
TABLE 39. GERMANY DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 40. GERMANY DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 41. UK DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE, 20172025 ($MILLION)
TABLE 42. UK DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 43. UK DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 44. FRANCE DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE, 20172025 ($MILLION)
TABLE 45. FRANCE DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 46. FRANCE DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 47. REST OF EUROPE DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE, 20172025 ($MILLION)
TABLE 48. REST OF EUROPE DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 49. REST OF EUROPE DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 50. EUROPE DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE, 20172025 ($MILLION)
TABLE 51. EUROPE DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 52. EUROPE DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 53. ASIA-PACIFIC DRUG ABUSE TESTING MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 54. JAPAN DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE, 20172025 ($MILLION)
TABLE 55. JAPAN DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 56. JAPAN DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 57. CHINA DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE, 20172025 ($MILLION)
TABLE 58. CHINA DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 59. CHINA DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 60. INDIA DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE, 20172025 ($MILLION)
TABLE 61. INDIA DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 62. INDIA DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 63. AUSTRALIA DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE, 20172025 ($MILLION)
TABLE 64. AUSTRALIA DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 65. AUSTRALIA DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 66. REST OF ASIA-PACIFIC DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE, 20172025 ($MILLION)
TABLE 67. REST OF ASIA-PACIFIC DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 68. REST OF ASIA-PACIFIC DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 69. ASIA-PACIFIC DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE, 20172025 ($MILLION)
TABLE 70. ASIA-PACIFIC DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 71. ASIA-PACIFIC DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 72. LAMEA DRUG ABUSE TESTING MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 73. BRAZIL DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE, 20172025 ($MILLION)
TABLE 74. BRAZIL DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 75. BRAZIL DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 76. SOUTH AFRICA DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE, 20172025 ($MILLION)
TABLE 77. SOUTH AFRICA DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 78. SOUTH AFRICA DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 79. SAUDI ARABIA DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE, 20172025 ($MILLION)
TABLE 80. SAUDI ARABIA DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 81. SAUDI ARABIA DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 82. TURKEY DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE, 20172025 ($MILLION)
TABLE 83. TURKEY DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 84. TURKEY DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 85. REST OF LAMEA DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE, 20172025 ($MILLION)
TABLE 86. REST OF LAMEA DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 87. REST OF LAMEA DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 88. LAMEA DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE, 20172025 ($MILLION)
TABLE 89. LAMEA DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE, 20172025 ($MILLION)
TABLE 90. LAMEA DRUG ABUSE TESTING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 91. ABBOTT: COMPANY SNAPSHOT
TABLE 92. ABBOTT: OPERATING SEGMENTS
TABLE 93. ABBOTT: PRODUCT PORTFOLIO
TABLE 94. BIO-RAD: COMPANY SNAPSHOT
TABLE 95. BIO-RAD: OPERATING SEGMENTS
TABLE 96. BIORAD: PRODUCT PORTFOLIO
TABLE 97. DANAHER: COMPANY SNAPSHOT
TABLE 98. DANAHER: OPERATING SEGMENTS
TABLE 99. DANAHER: PRODUCT PORTFOLIO
TABLE 100. DRGER: COMPANY SNAPSHOT
TABLE 101. DRGER: PRODUCT PORTFOLIO
TABLE 102. EXPRESS DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 103. EXPRESS DIAGNOSTICS: PRODUCT PORTFOLIO
TABLE 104. ROCHE: COMPANY SNAPSHOT
TABLE 105. ROCHE: OPERATING SEGMENTS
TABLE 106. ROCHE: PRODUCT PORTFOLIO
TABLE 107. LABCORP: COMPANY SNAPSHOT
TABLE 108. LABCORP: OPERATING SEGMENTS
TABLE 109. LABCORP: PRODUCT PORTFOLIO
TABLE 110. QUEST: COMPANY SNAPSHOT
TABLE 111. QUEST: OPERATING SEGMENTS
TABLE 112. QUEST: PRODUCT PORTFOLIO
TABLE 113. SEIMENS: COMPANY SNAPSHOT
TABLE 114. SEIMENS: PRODUCT SEGMENTS
TABLE 115. SEIMENS: PRODUCT PORTFOLIO
TABLE 116. THERMO FISHER: COMPANY SNAPSHOT
TABLE 117. THERMO FISHER: OPERATING SEGMENTS
TABLE 118. THERMO FISHER: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. DRUG ABUSE TESTING MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS, 2017
FIGURE 03. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 04. HIGH BARGAINING POWER OF BUYERS
FIGURE 05. LOW THREAT OF SUBSTITUTION
FIGURE 06. MODERATE THREAT OF NEW ENTRANTS
FIGURE 07. MODERATE COMPETITIVE RIVALRY
FIGURE 08. MARKET SHARE ANALYSIS, 2017
FIGURE 09. GLOBAL DRUG ABUSE TESTING MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 10. GLOBAL DRUG ABUSE TESTING MARKET, FOR ANALYZER BY REGION, 20172025 ($MILLION)
FIGURE 11. GLOBAL DRUG ABUSE TESTING MARKET, FOR IMMUNOASSAY ANALYZER BY REGION, 20172025 ($MILLION)
FIGURE 12. GLOBAL DRUG ABUSE TESTING MARKET, FOR CHROMATOGRAPHY ANALYZER BY REGION, 20172025 ($MILLION)
FIGURE 13. GLOBAL DRUG ABUSE TESTING MARKET, FOR BREATH ANALYZER BY REGION, 20172025 ($MILLION)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF RAPID TESTING DEVICES MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF CONSUMABLES MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 16. LABORATORY SERVICES MARKET, BY REGION, 20172025 ($MILLION)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF LABORATORY SERVICES MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF URINE SAMPLE MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF ORAL FLUID SAMPLE MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF BREATH SAMPLE MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF HAIR SAMPLE MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF OTHER SAMPLES MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF DRUG ABUSE TESTING MARKET FOR WORKPLACES AND SCHOOLS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF DRUG ABUSE TESTING MARKET FOR CRIMINIAL JUSTICE SYSTEMS & LAW ENFORCEMENT AGENCIES, BY COUNTRY, 2017 & 2025 (%)
FIGURE 25. COMPARATIVE SHARE ANALYSIS OF DRUG ABUSE TESTING MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2017 & 2025 (%)
FIGURE 26. COMPARATIVE SHARE ANALYSIS OF DRUG ABUSE TESTING MARKET FOR HOSPITALS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 27. ABBOTT: NET SALES, 20152017 ($MILLION)
FIGURE 28. ABBOTT: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 29. ABBOTT: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 30. BIO-RAD: NET SALES, 20152017 ($MILLION)
FIGURE 31. BIO-RAD: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 32. BIO-RAD: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 33. DANAHER: NET SALES, 20152017 ($MILLION)
FIGURE 34. DANAHER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 35. DANAHER: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 36. DRGER: NET SALES, 20152017 ($MILLION)
FIGURE 37. DRGER: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 38. ROCHE: NET SALES, 20152017 ($MILLION)
FIGURE 39. ROCHE: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 40. LABCORP: REVENUE, 20152017 ($MILLION)
FIGURE 41. LABCORP: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 42. LABCORP: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 43. QUEST: NET SALES, 20152017 ($MILLION)
FIGURE 44. QUEST: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 45. SEIMENS: NET SALES, 20152017 ($MILLION)
FIGURE 46. SEIMENS: REVENUE SHARE BY PRODUCT SEGMENT, 2017 (%)
FIGURE 47. SEIMENS: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 48. THERMO FISHER: NET SALES, 20152017 ($MILLION)
FIGURE 49. THERMO FISHER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 50. THERMO FISHER: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 01. DRUG ABUSE TESTING MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS, 2017
FIGURE 03. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 04. HIGH BARGAINING POWER OF BUYERS
FIGURE 05. LOW THREAT OF SUBSTITUTION
FIGURE 06. MODERATE THREAT OF NEW ENTRANTS
FIGURE 07. MODERATE COMPETITIVE RIVALRY
FIGURE 08. MARKET SHARE ANALYSIS, 2017
FIGURE 09. GLOBAL DRUG ABUSE TESTING MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 10. GLOBAL DRUG ABUSE TESTING MARKET, FOR ANALYZER BY REGION, 20172025 ($MILLION)
FIGURE 11. GLOBAL DRUG ABUSE TESTING MARKET, FOR IMMUNOASSAY ANALYZER BY REGION, 20172025 ($MILLION)
FIGURE 12. GLOBAL DRUG ABUSE TESTING MARKET, FOR CHROMATOGRAPHY ANALYZER BY REGION, 20172025 ($MILLION)
FIGURE 13. GLOBAL DRUG ABUSE TESTING MARKET, FOR BREATH ANALYZER BY REGION, 20172025 ($MILLION)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF RAPID TESTING DEVICES MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF CONSUMABLES MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 16. LABORATORY SERVICES MARKET, BY REGION, 20172025 ($MILLION)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF LABORATORY SERVICES MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF URINE SAMPLE MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF ORAL FLUID SAMPLE MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF BREATH SAMPLE MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF HAIR SAMPLE MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF OTHER SAMPLES MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF DRUG ABUSE TESTING MARKET FOR WORKPLACES AND SCHOOLS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF DRUG ABUSE TESTING MARKET FOR CRIMINIAL JUSTICE SYSTEMS & LAW ENFORCEMENT AGENCIES, BY COUNTRY, 2017 & 2025 (%)
FIGURE 25. COMPARATIVE SHARE ANALYSIS OF DRUG ABUSE TESTING MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2017 & 2025 (%)
FIGURE 26. COMPARATIVE SHARE ANALYSIS OF DRUG ABUSE TESTING MARKET FOR HOSPITALS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 27. ABBOTT: NET SALES, 20152017 ($MILLION)
FIGURE 28. ABBOTT: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 29. ABBOTT: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 30. BIO-RAD: NET SALES, 20152017 ($MILLION)
FIGURE 31. BIO-RAD: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 32. BIO-RAD: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 33. DANAHER: NET SALES, 20152017 ($MILLION)
FIGURE 34. DANAHER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 35. DANAHER: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 36. DRGER: NET SALES, 20152017 ($MILLION)
FIGURE 37. DRGER: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 38. ROCHE: NET SALES, 20152017 ($MILLION)
FIGURE 39. ROCHE: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 40. LABCORP: REVENUE, 20152017 ($MILLION)
FIGURE 41. LABCORP: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 42. LABCORP: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 43. QUEST: NET SALES, 20152017 ($MILLION)
FIGURE 44. QUEST: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 45. SEIMENS: NET SALES, 20152017 ($MILLION)
FIGURE 46. SEIMENS: REVENUE SHARE BY PRODUCT SEGMENT, 2017 (%)
FIGURE 47. SEIMENS: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 48. THERMO FISHER: NET SALES, 20152017 ($MILLION)
FIGURE 49. THERMO FISHER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 50. THERMO FISHER: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
